117053 ⎘
Hydrolases acting on peptide bonds, i.e. peptidases (3.4); Metalloendopeptidases (3.4.24) Gelatinase B (3.4.24.35), i.e. matrix metalloprotease 9 or MMP9
THERAPEUTIC MACROPHAGES
#2PROTEASE-CLEAVABLE MOIETIES AND METHODS OF USE THEREOF
#3CO-TRANSPLANTATION OF MMP-9 ENHANCED MESENCHYMAL STEM CELLS AND PANCREATIC ISLETS FOR THE TREATMENT OF DIABETES
#4BIOMARKERS FOR THE PREDICTION OF PRETERM BIRTH
#5PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#6METHOD OF MITIGATION OF INJURIES CAUSED BY SYSTEMIC GENOTOXIC STRESS
#7ONCOLYTIC VIRAL DELIVERY OF THERAPEUTIC POLYPEPTIDES
#8NOVEL IL-15 PRODRUGS AND METHODS OF USE THEREOF
#9SCREENING METHOD FOR LAMININ 511 PRODUCTION PROMOTING AGENT, BASAL EPIDERMAL LAYER STABILIZING AGENT, AND/OR EPIDERMAL STEM CELLS REDUCTION INHIBITING OR PROLIFERATION PROMOTING AGENT
#10TARGETED CHONDROITINASE ABC FUSION PROTEINS AND COMPLEXES THEREOF
#11Oncolytic viral delivery of therapeutic polypeptides
#12Antibodies to matrix metalloproteinase 9
#13IL-15 prodrugs and methods of use thereof
#14METHODS AND COMPOSITIONS FOR MODULATION OF MIGRATION OF NEUROGENIC CELLS
#15Inhibition of vascular matrix metalloproteinase-9 to treat ischemic injury
#16MMP9 inhibitors and uses thereof in the prevention or treatment of a depigmenting disorder
#17Screening method for laminin 511 production promoting agent, basal epidermal layer stabilizing agent, and/or epidermal stem cells reduction inhibiting or proliferation promoting agent
#18Methods and compositions for modulation of migration of neurogenic cells
#19Antibodies to matrix metalloproteinase 9
#20Compositions and multiplex assays for characterizing active proteases and their inhibitors
#21Method for quantifying therapeutic antibodies
#22Prostate cancer-associated secreted proteins
#23COMPOSITIONS AND METHODS FOR TREATING CANCER, INFLAMMATORY DISEASES AND AUTOIMMUNE DISEASES
#24Antibodies specific for MMP9
#25METHOD OF DETECTING HUMAN MATRIX METALLOPROTEINASE 9 USING ANTIBODIES
#26COMBINATION OF A JAK INHIBITOR AND AN MMP9 BINDING PROTEIN FOR TREATING INFLAMMATORY DISORDERS
#27Gelatinase inhibitors and prodrugs
#28Aptamers inhibiting the enzymatic activity of the MMP-9 protein
#29Polymer nanocomposites for early diagnosis of diseases
#30MATRIX METALLOPROTEINASSES AND USES THEREOF
#31METHODS AND COMPOSITIONS FOR TREATMENT OF TRAUMATIC BRAIN INJURY AND FOR MODULATION OF MIGRATION OF NEUROGENIC CELLS
#32Method of detecting human matrix metalloproteinase 9 using antibodies
#33Gelatinase inhibitors and prodrugs
#34METHODS FOR MODIFICATION OF TISSUES
#35Pharmaceutical compositions and methods for digesting atherosclerotic plaques
#36Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells
#37Regulators of MMP-9 and uses thereof
#38Gelatinase inhibitors and prodrugs
#39Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitor
#40REGULATORS OF MMP-9 AND USES THEROF
#41ENZYME MEDIATED DELIVERY SYSTEM